Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (191-200 of 332) with videos related to

Pageof 34
Sort By:
European Radiology|September 6, 2022
Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysisBrigit M Aarts, Fernando M Gomez, Marta Lopez-Yurda, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2015
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinomaAurelie Guislain, Jules Gadiot, Andrew Kaiser, et al.
European Urology|May 27, 2011
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancerThomas Powles, Christian Blank, Simon Chowdhury, et al.
European Urology|December 5, 2024
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary CancersPedro C Barata, Kevin K Zarrabi, Axel Bex, et al.
Minerva Urology and Nephrology|March 30, 2021
Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemicWei-Shen Tan, Maya Marchese, Marco Paciotti, et al.
European Urology Open Science|December 29, 2022
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal CancerKatharina Beyer, Christiaan Widdershoven, Lisa M Wintner, et al.
European Urology Open Science|August 7, 2023
A Systematic Review of Patient Race, Ethnicity, Socioeconomic Status, and Educational Attainment in Prostate Cancer Treatment Randomised Trials-Is the Evidence Base Applicable to the General Patient Population?Siddhant Patki, Julian Aquilina, Rebecca Thorne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary CancersMarinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, et al.
Urology|August 12, 2020
Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert InquiryKatharina Boehm, Anita Thomas, Axel Bex, et al.
European Urology Focus|November 27, 2025
A Systematic Review and Meta-analysis of Oncological Outcomes of Treated and Untreated Complex Cystic Renal MassesFederica Sordelli, Hannah Warren, Namir Khalil, et al.
Pageof 34

Showing results (191-200 of 332) with videos related to

Sort By:
Pageof 34
European Radiology|September 6, 2022
Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysisBrigit M Aarts, Fernando M Gomez, Marta Lopez-Yurda, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2015
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinomaAurelie Guislain, Jules Gadiot, Andrew Kaiser, et al.
European Urology|May 27, 2011
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancerThomas Powles, Christian Blank, Simon Chowdhury, et al.
European Urology|December 5, 2024
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary CancersPedro C Barata, Kevin K Zarrabi, Axel Bex, et al.
Minerva Urology and Nephrology|March 30, 2021
Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemicWei-Shen Tan, Maya Marchese, Marco Paciotti, et al.
European Urology Open Science|December 29, 2022
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal CancerKatharina Beyer, Christiaan Widdershoven, Lisa M Wintner, et al.
European Urology Open Science|August 7, 2023
A Systematic Review of Patient Race, Ethnicity, Socioeconomic Status, and Educational Attainment in Prostate Cancer Treatment Randomised Trials-Is the Evidence Base Applicable to the General Patient Population?Siddhant Patki, Julian Aquilina, Rebecca Thorne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary CancersMarinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, et al.
Urology|August 12, 2020
Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert InquiryKatharina Boehm, Anita Thomas, Axel Bex, et al.
European Urology Focus|November 27, 2025
A Systematic Review and Meta-analysis of Oncological Outcomes of Treated and Untreated Complex Cystic Renal MassesFederica Sordelli, Hannah Warren, Namir Khalil, et al.
Pageof 34